Psilocybin’s Legal Status in South Africa: Schedule 7 and the Constitutional Challenge

In South Africa, psilocybin — the naturally occurring compound found in certain mushrooms — is one of the most tightly controlled substances in the country. It is listed in Schedule 7 of the Medicines and Related Substances Act, the most restrictive schedule, the same tier that contains heroin. This article explains what that classification means in law and outlines the constitutional challenge that seeks to change it. It is general legal-context information, not legal advice.

What Schedule 7 means

South Africa’s Medicines and Related Substances Act (Act 101 of 1965) sorts substances into schedules from 0 to 8, administered by the South African Health Products Regulatory Authority (SAHPRA). Higher schedules carry tighter controls. Schedule 7 covers substances deemed to have a high potential for abuse and no recognised medical use in the ordinary regulatory sense, which means possession, use, manufacture and supply are prohibited without a specific permit from the Director-General of Health.

Because psilocybin and psilocin sit in Schedule 7, they are treated in law much like heroin, even though their pharmacology and risk profile differ substantially. Researchers wishing to study them must obtain permits, which has historically slowed formal clinical work in the country.

The cannabis precedent

The legal landscape shifted in 2018 when the Constitutional Court, in Minister of Justice and Constitutional Development v Prince, decriminalised the private use and cultivation of cannabis by adults in private. The Court held that the blanket prohibition unjustifiably limited the constitutional right to privacy. That judgment established a template: a criminal prohibition on a substance can be tested against the Bill of Rights, and can fall if the state cannot justify it.

Advocates for psilocybin reform point to this precedent as a route to re-examine Schedule 7’s treatment of psilocybin, arguing that similar privacy and dignity considerations apply.

The constitutional challenge

A constitutional challenge to the scheduling of psilocybin has argued that criminalising personal, private use infringes rights to privacy, freedom of belief, and cognitive liberty, and that the state lacks a rational, evidence-based justification for placing psilocybin in the most restrictive schedule. The core legal question mirrors the cannabis case: whether a total prohibition is a proportionate limitation of constitutional rights given the current scientific understanding of the substance.

Litigation of this kind typically moves slowly through the High Court and, potentially, to the Constitutional Court. Regardless of outcome, the case has drawn public attention to how South Africa classifies psychedelic compounds.

Where reform stands

As of this writing, psilocybin remains in Schedule 7 and personal use remains unlawful pending any change in legislation or a court ruling to the contrary. Reform efforts focus on rescheduling to enable research and regulated therapeutic access rather than on unrestricted availability. Anyone seeking the current legal position should consult SAHPRA and the published schedules directly, as the law can change.